SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-204578
Filing Date
2023-08-07
Accepted
2023-08-07 09:01:34
Documents
22
Period of Report
2023-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d480632d8k.htm   iXBRL 8-K 45421
2 EX-10.1 d480632dex101.htm EX-10.1 120762
3 EX-10.2 d480632dex102.htm EX-10.2 92682
4 EX-10.3 d480632dex103.htm EX-10.3 45793
5 EX-99.1 d480632dex991.htm EX-99.1 19958
6 EX-99.2 d480632dex992.htm EX-99.2 18239
10 GRAPHIC g480632g0804133558693.jpg GRAPHIC 3062
11 GRAPHIC g480632g0804133558932.jpg GRAPHIC 4036
12 GRAPHIC g480632g0804133831163.jpg GRAPHIC 4466
13 GRAPHIC g480632g0807075913484.jpg GRAPHIC 3440
14 GRAPHIC g480632g0807080719682.jpg GRAPHIC 3423
  Complete submission text file 0001193125-23-204578.txt   587261

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pstx-20230804.xsd EX-101.SCH 2838
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20230804_lab.xml EX-101.LAB 18737
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20230804_pre.xml EX-101.PRE 11699
16 EXTRACTED XBRL INSTANCE DOCUMENT d480632d8k_htm.xml XML 3468
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 231145826
SIC: 2836 Biological Products, (No Diagnostic Substances)